Cambrian Stock

cambrianbio.comBioTechFounded: 2019Funding to Date: $149.86MM

Cambrian is a drug-discovery and distribution company focusing on developing curative therapies for specific diseases then subsequently deploying them as preventative solutions to improve the quality of life as we age.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Cambrian, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Other companies like Cambrian in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$197.73MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM